Packaging, fill, and fill-finish services for oligonucleotides cover the final controlled handling steps that transform purified material into a ready-to-use research, diagnostic, or preclinical product. These services may include formulation, dilution, aliquoting, tube or vial filling, plate formatting, labeling, and shipment preparation.
tube or plate formatting
liquid or lyophilized
custom formulation
labeling and traceability
ISO 9000:2015/ISO13485:2016
45+ Years of Expertise
U.S. Facilities - Texas
Although often treated as a logistics step, final fill and packaging can strongly affect reproducibility, automation compatibility, and material integrity. Proper final formatting reduces handling errors, supports consistent assay setup, and helps preserve oligonucleotide performance across downstream workflows such as qPCR, NGS, RNA imaging, probe-based detection, and therapeutic evaluation.
For modified oligonucleotides, fluorescent probes, conjugates, and higher-value assay materials, controlled final packaging can be just as important as synthesis and purification. Matching concentration, fill volume, buffer system, storage format, and labeling scheme to the end use helps reduce rework and simplifies adoption into the user’s workflow.
Why this matters: Packaging, fill, and fill-finish services are not only about delivery format. They help define whether an oligonucleotide arrives ready for immediate use, high-throughput automation, controlled storage, or regulated workflow integration.
These services are designed for research, diagnostic, and preclinical workflows. For GMP or clinical-grade fill-finish requirements, additional specifications may apply.